Pulsed versus continuous terbinafine dosing in the treatment of dermatophyte onychomycosis

Journal of Dermatological Treatment

Volumn 15, Issue 5, 2004, Pages 315-320

  Pavlotsky, F ^a   Armoni, G ^b   Shemer, A ^b   Trau, H ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b NONE

Author keywords

Dermatophytes; Onychomycosis; Pulsed Terbinafine

Indexed keywords

TERBINAFINE;

ACNE; ADOLESCENT; ADULT; AGED; ALLERGIC REACTION; ARTICLE; BLOOD DYSCRASIA; CLINICAL PROTOCOL; CONTROLLED STUDY; DERMATOPHYTE; DIZZINESS; DRUG COST; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; ONYCHOMYCOSIS; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; PRURITUS; PURPURA; RETROSPECTIVE STUDY; SCHOOL CHILD; SIDE EFFECT; TASTE DISORDER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CHILD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; NAPHTHALENES; ONYCHOMYCOSIS; PULSE THERAPY, DRUG; RETROSPECTIVE STUDIES;

EID: 7044271139     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.1080/09546630410018076     Document Type: Article

References (32)

1. Baudraz-Rosselet F, Rakosi T, Will PB, Kenzelmann R, Treatment onychomycosis with terbinafine. Br J Dermatol (1992) 126 (suppl 39): 40-6.
2. Van der Schroeff JG, Girkel PKDS, Crijns MB et al, A randomized treatment duration finding study of terbinafine in onychomycosis, Br J Dermatol (1992) 126 (suppl): 36-9.
3. Villars VV, Jones TC, Special features of the clinical use of terbinafine in the treatment of fungal diseases. Br J Dermatol (1992) 126 (suppl 39): 61-9.
4. Alpsoy E, Yilmaz E, Basaran E, Intermittent therapy with terbinafine for dermatophyte toe onychomycosis: a new approach. J Dermatol (1996) 23: 259-62.
5. Tosti A, Piraccini BM, Stinchi C et al, Treatment of dermatophyte nail infections: an open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy, J Am Acad Dermatol (1996a) 34: 595-600.
6. Gupta AK, Lynde CW, Konnikov N, Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis. J Am Acad Dermatol (2001) 44: 485-91.
7. Dixon WJ (Chief editor). BMDP statistical software. University of California Press: Los Angeles, CA, 1993.
8. Hall M, Monka C, Krupp P, O'Sullivan D, Safety of oral terbinafine; results of a postmarketing surveillance study in 25,884 patients. Arch Dermatol (1997) 133: 1213-19.
9. Villars V, Jones TC, Clinical efficacy and tolerability of terbinafine (Lamisil) - a new topical and systemic fungicidal drug for treatment of dermatomycoses. Clin Exp Dermatol (1989) 14: 124-7.
10. Korting HC, Schafer-Korting M, Is tinea unguium still widely incurable? A review three decades after the introduction of griseofulvin. Arch Dermatol (1992) 128: 243-8.
11. Brautigam M, Nolting S, Schopf RE et al, German randomized double-blind multicentre comparison of terbinafine and itraconazole in the treatment of toenail tinea infection. Br Med J (1996) 134 (suppl 46): 18-21.
12. Brautigam M, Terbinafine vs itraconazole: a controlled clinical comparison in onychomycosis of the toenails. J Am Acad Dermatol (1998) 38: S53-6.
13. De Backer M, De Vroey C, Lesaffre E et al, Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day. J Am Acad Dermatol (1998) 38: S57-63.
14. Arikian SR, Einarson TR, Kobelt-Nguyen G et al, A multinational pharmacoeconomic analysis of oral therapies for onychomycosis. Br J Dermatol (1994) 130 (suppl 43): 35-44.
15. Einarson TR, Arikian SR, Shear NH, Cost-effectiveness analysis for onychomycosis therapy in Canada from a government perspective. Br J Dermatol (1994) 130 (suppl 43): 32-4.
16. Marchetti A, Piech CT, McGhan WF et al, Pharmacoeconomic analysis of oral therapies for onychomycosis: a US model. Clin Ther (1996) 18: 757-77.
17. Gupta AK, Pharmacoeconomic analysis of oral antifungal therapies used to treat dermatophyte onychomycosis of the toenails. A US analysis. Pharmacoeconomics (1998) 13: 243-56.
18. Angello JT, Voytovich RM, Jan SA, A cost/efficacy analysis of oral antifungals indicated for the treatment of onychomycosis: griseofulvin, itraconazole, and terbinafine. Am J Manag Care (1997) 3: 443-50.
19. La Placa M Jr, Stinchi C, Ventura N et al, Terbinafine vs griseofulvin in the treatment of onychomycosis due to dermatophytes. G Ital Dermatol Venereol (1994) 129: 19-22.
20. Cribier B, Grosshans E, Efficacite et tolerance de la terbinafine (Lamisil®) dans une serie de 50 onychomycoses a dermatophytes. Ann Derm Venereol (1994) 121: 15-20.
21. Goodflelds MJD, Short-duration therapy with terbinafine for dermatophyte onychomycosis: a multicentre trial. Br J Dermatol (1992) 126 (suppl 39): 33-5.
22. Faergemann J, Zehender H, Millerioux L, Levels of terbinafine in plasma, stratum corneum, dermisepidermis (without stratum corneum), hair and nails during and after 250 mg terbinafine orally once daily for 7 and 14 days. Clin Exp Dermatol (1994) 19: 121-6.
23. Leyden J, Pharmacokinetics and pharmacology of terbinafine and itraconazole. J Am Acad Dermatol (1998) 38: S42-7.
24. Finlay AY, Parmacokinetics of terbinafine in the nail, Br J Dermatol (1992) 126 (suppl 39): 28-32.
25. Schatz F, Brautigam M, Dobrowolski E et al, Nail incorporation kinetics of terbinafine in onychomycosis patients. Clin Exp Dermatol (1995) 20: 377-83.
26. Debruyne D, Coquerel A, Pharmacokinetics of antifungal agents in onychomycoses. Clin Pharmacokinet (2001) 40: 441-72.
27. Roberts DT, The clinical efficacy of terbinafine in the treatment of fungal infections of nails. Rev Contemp Pharmacother (1997) 8: 299-312.
28. Glyn E, Evans V, Sigurgeirsson B, Double-blind, randomized study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. Br Med J (1999) 318: 1031-5.
29. Gupta AK, Konnikov N, Lynde CW, Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly. J Am Acad Dermatol (2001) 44: 479-84.
30. Shuster S, Munro CS, Single-dose treatment of fungal nail disease. Lancet (1992) 339: 1066.
31. Gupta AK, Adam B, Terbinafine pulse therapy is effective in tinea capitis. Pediatr Dermatol (1998) 15: 56-8.
32. Tosti A, Piraccini BM, Stinchi C, Colombo MD, Relapses of onychomycosis after successful treatment with systemic antifungals: a three-year follow up. Dermatology (1998) 197: 162-6.